Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.62 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.60 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9822809 | 0.94 | FOLH1 (0.69) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL14940816 | 0.94 | FOLH1 (0.69) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29532240 | 0.94 | FOLH1 (0.69) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| Hydrochloric Acid SCHEMBL30698091 | 0.93 | FOLH1 (0.67) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL30683246 | 0.91 | FOLH1 (0.66) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29477112 | 0.91 | FOLH1 (0.66) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29531738 | 0.91 | FOLH1 (0.66) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29822390 | 0.90 | FOLH1 (0.68) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL28610620 | 0.90 | LTA4H (0.67) | OPRD1LTA4HMME | |
| SCHEMBL3059707 | 0.88 | FOLH1 (0.62) | FOLH1OPRD1LTA4HNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680263-B2 | Carbohydrate-based drug delivery polymers and conjugates thereof | NEKTAR THERAPEUTICS (US) | 2014-03-25 | — | — | US | disclosed |
| US-20110171716-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | NEKTAR THERAPEUTICS (US) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171716-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | STT3B, STT3A, DDOST | FOLH1 287/4885OPRD1 3859/4885LTA4H 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.